Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
McKesson
Queensland Health
Farmers Insurance
Daiichi Sankyo
Harvard Business School
Covington
Julphar

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050593

« Back to Dashboard

NDA 050593 describes ERYC SPRINKLES, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the ERYC SPRINKLES profile page.

The generic ingredient in ERYC SPRINKLES is erythromycin. There are one hundred and two drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 050593
Tradename:ERYC SPRINKLES
Applicant:Hospira
Ingredient:erythromycin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 050593

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, DELAYED REL PELLETS;ORALStrength125MG
Approval Date:Jul 22, 1985TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
Merck
US Department of Justice
Colorcon
Fuji
Federal Trade Commission
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.